Group One Trading
VRDN icon

Group One Trading’s Viridian Therapeutics VRDN Stock Holding History

Group One Trading’s Portfolio VRDN Stock Details VRDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.2M Buy
+61,500
New +$1.83M ﹤0.01% 2540
2025
Q4 		– Sell
-5,000
Closed -$108K – 9251
2025
Q3 		$108K Sell
5,000
-4,600
-48% -$83K ﹤0.01% 5273
2025
Q2 		$134K Buy
9,600
+7,700
+405% +$105K ﹤0.01% 4714
2025
Q1 		$25.6K Sell
1,900
-90,500
-98% -$1.54M ﹤0.01% 5651
2024
Q4 		$1.77M Buy
92,400
+42,100
+84% +$915K ﹤0.01% 2034
2024
Q3 		$1.14M Buy
50,300
+34,900
+227% +$571K ﹤0.01% 2183
2024
Q2 		$200K Buy
+15,400
New +$213K ﹤0.01% 3380
2024
Q1 		– Sell
-100
Closed -$2.18K – 8031
2023
Q4 		$2.18K Sell
100
-5,100
-98% -$80.5K ﹤0.01% 6794
2023
Q3 		$79.8K Sell
5,200
-24,800
-83% -$473K ﹤0.01% 4658
2023
Q2 		$714K Buy
+30,000
New +$769K ﹤0.01% 2664
2022
Q4 		– Sell
-100
Closed -$2K – 8158
2022
Q3 		$2K Buy
+100
New +$1.8K ﹤0.01% 7215

Other funds holding VRDN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return